Hemorrhage
Concept
Vocabulary Service
Overview
subject area of
-
2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Academic Article
-
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants Academic Article
-
2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis Academic Article
-
2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Academic Article
-
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants Academic Article
-
2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants Academic Article
-
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 Academic Article
-
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE Academic Article
-
6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII Academic Article
-
Transfusion practice
in the bleeding critically ill: An international online survey—The
TRACE
‐2 survey Academic Article
-
d-Dimer Testing to Determine the Duration of Anticoagulation Therapy Academic Article
-
d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy Academic Article
-
A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement Academic Article
-
A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis Academic Article
-
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease Academic Article
-
A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism Academic Article
-
A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee Implantation Academic Article
-
A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism Academic Article
-
A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome Academic Article
-
A Historical Perspective on the Reversal of Anticoagulants Academic Article
-
A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke Academic Article
-
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction Academic Article
-
A Novel Type 2A von Willebrand Factor Mutation (V1499E) Associated With Variable Clinical Expression Academic Article
-
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation Academic Article
-
A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial Academic Article
-
A PoTENtial Antidote Academic Article
-
A Population-Based Assessment of the Drug Interaction Between Levothyroxine and Warfarin Academic Article
-
A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery Academic Article
-
A Registry-Based Randomized Trial Comparing Radial and Femoral Approaches in Women Undergoing Percutaneous Coronary Intervention Academic Article
-
A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip Replacement Academic Article
-
A comparison of methods for prediction of pharmacokinetics when switching to extended half-life products in hemophilia A patients Academic Article
-
A comparison of the anti thrombotic and haemorrhagic effects of low molecular weight heparin fractions: The influence of the method of preparation Academic Article
-
A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system Academic Article
-
A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits. Academic Article
-
A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty Academic Article
-
A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia Academic Article
-
A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery Academic Article
-
A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss Academic Article
-
A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders Academic Article
-
A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo Academic Article
-
A molecular genetic study of factor XI deficiency Academic Article
-
A multicenter observational survey of management strategies in 442 pregnancies with suspected placenta accreta spectrum Academic Article
-
A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation Academic Article
-
A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy Academic Article
-
A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia (CME) Academic Article
-
A new visual indicator of chlamydial cervicitis? Conference Paper
-
A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment Academic Article
-
A novel antithrombin-heparin covalent complex Academic Article
-
A novel endoscopic treatment for ureteric remnant hemorrhage post laparoscopic radical nephrectomy Academic Article
-
A novel long‐acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A Phase II evaluation Academic Article
-
A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease. Academic Article
-
A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban Academic Article
-
A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes Academic Article
-
A preliminary application of a haemophilia value framework to emerging therapies in haemophilia Academic Article
-
A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma. Academic Article
-
A prospective cohort study of light transmission platelet aggregometry for bleeding disorders: Is testing native platelet-rich plasma non-inferior to testing platelet count adjusted samples? Academic Article
-
A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery Academic Article
-
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Academic Article
-
A randomised, double blind comparison of tecarfarin, a novel vitamin K antagonist, with warfarin Academic Article
-
A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology Academic Article
-
A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia Academic Article
-
A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT) Academic Article
-
A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer Academic Article
-
A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin Academic Article
-
A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip Academic Article
-
A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura Academic Article
-
A study of the agreement between patient self-assessment and study personnel assessment of bleeding symptoms Academic Article
-
A study protocol for a randomised controlled trial evaluating clinical effects of platelet transfusion products: the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) trial Academic Article
-
A systematic review of definitions and reporting of bleeding outcome measures in haemophilia Academic Article
-
A unified method for regional anticoagulation of blood. Academic Article
-
ARTS: A Large, International Trial of Thromboprophylaxis in Intra-abdominal, Gynecologic, and Urologic Surgery Academic Article
-
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease Academic Article
-
AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery – TREK: a dose-ranging study Academic Article
-
Abelacimab for Prevention of Venous Thromboembolism Academic Article
-
Abnormal hemostasis in a knock‐in mouse carrying a variant of factor IX with impaired binding to collagen type IV Academic Article
-
Accuracy of a Portable International Normalization Ratio Monitor in Outpatients Receiving Long-Term Oral Anticoagulant Therapy Academic Article
-
Accuracy of efficient data methods to determine the incidence of hospital-acquired thrombosis and major bleeding in medical and surgical inpatients: a multicentre observational cohort study in four UK hospitals Academic Article
-
Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years Academic Article
-
Acquired Hemophilia A Academic Article
-
Acquired hemophilia masked by warfarin therapy Academic Article
-
Acral Hemorrhagic Darier’s Disease Academic Article
-
Activated Clotting Time to Guide Heparin Dosing in Non–ST-Segment–Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors Academic Article
-
Activated Partial Thromboplastin Time and Outcome After Thrombolytic Therapy for Acute Myocardial Infarction Academic Article
-
Activated prothrombin complex concentrate for dabigatran-associated bleeding Academic Article
-
Acute management of bleeding in patients on novel oral anticoagulants Academic Article
-
Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants Academic Article
-
Acute reversal of anticoagulant-induced bleeding complications. Academic Article
-
Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation Academic Article
-
Additional Events in the RE-LY Trial Academic Article
-
Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia Academic Article
-
Adherence to anticoagulant treatment with dabigatran in a real‐world setting Academic Article
-
Adherence to apixaban for extended thromboprophylaxis after major abdominal or pelvic surgery for cancer: A prospective cohort study Academic Article
-
Adjudicating bleeding events in a platelet dose study: impact on outcome results and challenges Academic Article
-
Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness Academic Article
-
Adjusted Subcutaneous Heparin or Continuous Intravenous Heparin in Patients with Acute Deep Vein Thrombosis Academic Article
-
Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis Academic Article
-
Adjusted dose continuous infusion of factor VIII in patients with haemophilia A Academic Article
-
Adults with first-time nephrotic syndrome had increased risk for thromboembolic events, higher near time of diagnosis Academic Article
-
Advances in Antithrombotic Therapy: Novel Agents Academic Article
-
Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes Academic Article
-
Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study Academic Article
-
After PCI in AF, dual antithrombotic therapy with dabigatran reduced bleeding compared with triple therapy Academic Article
-
After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding Academic Article
-
Alcohol consumption and risk of cardiovascular outcomes and bleeding in patients with established atrial fibrillation Academic Article
-
Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis. Academic Article
-
An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction Academic Article
-
An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1 Academic Article
-
An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: A meta-analysis of contemporary randomized controlled trials Academic Article
-
An overview of clinical trials of low molecular weight heparin fractions. Academic Article
-
An unusual presentation of neonatal adrenal hemorrhage Academic Article
-
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation Academic Article
-
Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study Academic Article
-
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors Academic Article
-
Andexanet Alfa for Bleeding with Factor Xa Inhibitors Academic Article
-
Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with Edoxaban Academic Article
-
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity Academic Article
-
Andexanet alfa for reversal of factor Xa inhibitors: a critical review of the evidence Academic Article
-
Andexanet alfa for the treatment of hemorrhage Academic Article
-
Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis Academic Article
-
Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE‐LY trial Academic Article
-
Anemia-Induced Bleeding in Patients with Platelet Disorders Academic Article
-
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial Academic Article
-
Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add? Academic Article
-
Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis Academic Article
-
Anticoagulant therapy after acute myocardial infarction Academic Article
-
Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis Academic Article
-
Anticoagulant-Related Bleeding and Mortality ∗ Academic Article
-
Anticoagulants in Patients with Atrial Fibrillation and End-Stage Renal Disease Academic Article
-
Anticoagulants in heart disease: current status and perspectives Academic Article
-
Anticoagulants in pregnancy: A review of indications and complications Academic Article
-
Anticoagulation Therapy in Children Academic Article
-
Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes Academic Article
-
Anticoagulation and Bleeding: A Pooled Analysis of Lung Cancer Trials of the NCIC Clinical Trials Group Academic Article
-
Anticoagulation for Atrial Fibrillation: State of the Art and Recommendations for a Quickly Moving Target Academic Article
-
Anticoagulation for newly diagnosed atrial fibrillation and 90-day rates of stroke and bleeding Academic Article
-
Anticoagulation for perioperative thromboprophylaxis in people with cancer Academic Article
-
Anticoagulation for prosthetic heart valves Academic Article
-
Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Academic Article
-
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer Academic Article
-
Anticoagulation management in patients with mechanical heart valves having pacemaker or defibrillator insertion Academic Article
-
Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: Wide variability of perioperative bridging in Canada Academic Article
-
Antidotes for Novel Oral Anticoagulants Academic Article
-
Antiphospholipid antibody syndrome Academic Article
-
Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke Academic Article
-
Antiplatelet Therapy versus Anticoagulation after Surgical Bioprosthetic Aortic Valve Replacement: A Systematic Review and Meta-Analysis Academic Article
-
Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials Academic Article
-
Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair Academic Article
-
Antithrombotic Agents Academic Article
-
Antithrombotic Therapy After Acute Ischemic Stroke in Patients With Atrial Fibrillation Academic Article
-
Antithrombotic Therapy After Coronary Artery Stenting in Patients With Atrial Fibrillation Academic Article
-
Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes Academic Article
-
Antithrombotic Therapy for Atrial Fibrillation Academic Article
-
Antithrombotic Therapy in Neonates and Children Academic Article
-
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention Academic Article
-
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Academic Article
-
Antithrombotic Therapy in Peripheral Artery Disease: Risk Stratification and Clinical Decision Making Academic Article
-
Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses Academic Article
-
Antithrombotic and bleeding effects of glycosaminoglycans with different degrees of sulphation Academic Article
-
Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding Academic Article
-
Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines Academic Article
-
Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation Academic Article
-
Antithrombotic therapy in atrial fibrillation. Academic Article
-
Antithrombotics in stable peripheral artery disease Academic Article
-
Apixaban for Extended Treatment of Venous Thromboembolism Academic Article
-
Apixaban in Acute Coronary Syndromes Academic Article
-
Apixaban in Patients with Atrial Fibrillation Academic Article
-
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer Academic Article
-
Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement Academic Article
-
Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients Academic Article
-
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome Academic Article
-
Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Academic Article
-
Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions. Academic Article
-
Approaches to Diagnosing and Managing Anticoagulant-Related Bleeding Academic Article
-
Approaches to investigating common bleeding disorders: An evaluation of North American coagulation laboratory practices Academic Article
-
Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery Academic Article
-
Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement Academic Article
-
Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients Without Atrial Fibrillation? Evidence From Randomized Clinical Trials Academic Article
-
Are older patients with mechanical heart valves at increased risk? Academic Article
-
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia Academic Article
-
Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia Academic Article
-
Aspiration thrombectomy prior to percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis Academic Article
-
Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty Academic Article
-
Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke Academic Article
-
Aspirin for the Prevention of Recurrent Venous Thromboembolism Academic Article
-
Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery Academic Article
-
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty Academic Article
-
Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding Academic Article
-
Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial Academic Article
-
Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral Anticoagulants Academic Article
-
Assessment of Outpatient Treatment of Deep-Vein Thrombosis With Low-Molecular-Weight Heparin Academic Article
-
Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta‐analysis of randomized controlled trials Academic Article
-
Assessment of effectiveness of major bleeding management: proposed definitions for effective hemostasis: communication from the SSC of the ISTH Academic Article
-
Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation Academic Article
-
Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: Insights from the Global Registry of Acute Coronary Events Academic Article
-
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials Academic Article
-
Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta‐analysis Academic Article
-
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation Academic Article
-
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism Academic Article
-
Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation Academic Article
-
Atrial fibrillation in heart failure: stroke risk stratification and anticoagulation Academic Article
-
Azathioprine and diffuse alveolar haemorrhage: the pharmacogenetics of thiopurine methyltransferase Academic Article
-
BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study Academic Article
-
BAY 81-8973 Efficacy and Safety in Previously Untreated and Minimally Treated Children with Severe Hemophilia A: The LEOPOLD Kids Trial Academic Article
-
Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach Academic Article
-
Balancing the Benefits and Risks of 2 Doses of Dabigatran Compared With Warfarin in Atrial Fibrillation Academic Article
-
Balloon tamponade vs. endoscopic sclerotherapy: In the management of active variceal hemorrhage Academic Article
-
Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: A multicenter survey Academic Article
-
Barriers and potential solutions toward optimal prophylaxis against deep vein thrombosis for hospitalized medical patients: A survey of healthcare professionals Academic Article
-
Baseline Risks of Venous Thromboembolism and Major Bleeding are Crucial in Decision-making on Thromboprophylaxis Academic Article
-
Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (COAPT) Academic Article
-
Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial Academic Article
-
Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups Academic Article
-
Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty Academic Article
-
Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia Academic Article
-
Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome Academic Article
-
Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials Academic Article
-
Benefit–Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness Academic Article
-
Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa) Academic Article
-
Beyond Unfractionated Heparin and Warfarin Academic Article
-
Bivalirudin Academic Article
-
Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Initially Treated with Fondaparinux: Results from an International, Multicenter, Randomized Pilot Study ( Academic Article
-
Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation Academic Article
-
Bleeding Complications and Management on anticoagulant therapy Academic Article
-
Bleeding Complications in Patients with Acute Coronary Syndromes: Are They Important and How Can We Prevent Them? Academic Article
-
Bleeding Risk in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Systematic Review and Meta-Analysis Academic Article
-
Bleeding and antidotes in new oral anticoagulants Academic Article
-
Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes Academic Article
-
Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing Academic Article
-
Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry Academic Article
-
Bleeding and thrombotic problems in a patient with alpha2 plasmin inhibitor deficiency Academic Article
-
Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency Academic Article
-
Bleeding associated with antithrombotic therapy. Academic Article
-
Bleeding complications in acute coronary syndromes and percutaneous coronary intervention: predictors, prognostic significance, and paradigms for reducing risk. Academic Article
-
Bleeding complications in immune thrombocytopenia Academic Article
-
Bleeding during critical illness: A prospective cohort study using a new measurement tool Academic Article
-
Bleeding events with dabigatran or warfarin in patients with venous thromboembolism Academic Article
-
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology Academic Article
-
Bleeding in patients with renal insufficiency: A practical guide to clinical management Academic Article
-
Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation Academic Article
-
Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents Academic Article
-
Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta‐analysis Academic Article
-
Bleeding risks associated with inheritance of the Quebec platelet disorder Academic Article
-
Bleeding risks associated with vitamin K antagonists Academic Article
-
Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience Academic Article
-
Bleeding with direct oral anticoagulants vs warfarin: clinical experience Academic Article
-
Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures Academic Article
-
Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study Academic Article
-
Bone marrow biopsy morbidity and mortality: 2002 data. Academic Article
-
Bridge Therapy Outcomes in Patients With Mechanical Heart Valves Academic Article
-
Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery Academic Article
-
Bridging therapy in patients on long‐term oral anticoagulants who require surgery: the Prospective Peri‐operative Enoxaparin Cohort Trial (PROSPECT) Academic Article
-
Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin Academic Article
-
Bruton’s tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation Academic Article
-
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders Academic Article
-
Can activated recombinant factor VII be used to postpone the exposure of infants to factor VIII until after 2 years of age? Academic Article
-
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter Academic Article
-
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE Academic Article
-
Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants Academic Article
-
Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial) Academic Article
-
Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention Academic Article
-
Central nervous system bleeding in patients with rare bleeding disorders Academic Article
-
Certainty ranges facilitated explicit and transparent judgments regarding evidence credibility Academic Article
-
Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial Academic Article
-
Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials Academic Article
-
Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials Academic Article
-
Circulating heparin‐like anticoagulants: Case report and review of literature Academic Article
-
Clinical Experience With the New Oral Anticoagulants for Treatment of Venous Thromboembolism Academic Article
-
Clinical Experience with Anticoagulant Therapy During Pregnancy Academic Article
-
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study Academic Article
-
Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism Academic Article
-
Clinical Relevance of Bleeding Index Academic Article
-
Clinical Use of Low Molecular Weight Heparins and Heparinoids Academic Article
-
Clinical and pathological findings in dogs following supralethal total body irradiation with and without infusion of autologous long-term marrow culture cells. Academic Article
-
Clinical impact of neonatal thrombocytopenia Academic Article
-
Clinical implications of reversal agents for direct oral anticoagulants Academic Article
-
Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin Academic Article
-
Clinical profile of patients with systemic autoimmune diseases treated in the intensive care unit who developed diffuse alveolar haemorrhage – an observational retrospective cohort study Academic Article
-
Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications Academic Article
-
Clinical trials evaluating pathogen-reduced platelet products: methodologic issues and recommendations Academic Article
-
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events Academic Article
-
Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis Academic Article
-
Closure of a Percutaneous Endoscopic Gastrostomy-Associated Nonhealing Gastrocutaneous Fistula Using Endoscopic Hemoclips Academic Article
-
Coagulation and Fibrinolytic Profile of Paediatric Patients Undergoing Cardiopulmonary Bypass Academic Article
-
Coagulopathy related to dilution and hypotension during massive transfusion Academic Article
-
Cochrane in CORR ®: Topical Application of Tranexamic Acid for the Reduction of Bleeding (Review) Academic Article
-
Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease Academic Article
-
Comparative effectiveness and safety of direct acting oral anticoagulants in nonvalvular atrial fibrillation for stroke prevention: a systematic review and meta-analysis Academic Article
-
Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study Academic Article
-
Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol Academic Article
-
Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation: A retrospective cohort study Academic Article
-
Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE Academic Article
-
Comparative effects of heparin and LMW heparin on hemostasis Conference Paper
-
Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes Academic Article
-
Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study Academic Article
-
Comparing bleed frequency and factor concentrate use between haemophilia A and B patients Academic Article
-
Comparing mortality in patients with atrial fibrillation who are receiving a direct‐acting oral anticoagulant or warfarin: a meta‐analysis of randomized trials Academic Article
-
Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis Conference Paper
-
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor Academic Article
-
Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin Academic Article
-
Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy Academic Article
-
Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes Academic Article
-
Comparison of High-Dose With Low-Dose Aspirin in Patients With Mechanical Heart Valve Replacement Treated With Oral Anticoagulant Academic Article
-
Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction Academic Article
-
Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism Academic Article
-
Comparison of Radial Access, Guided Femoral Access, and Non-Guided Femoral Access Among Women Undergoing Percutaneous Coronary Intervention. Academic Article
-
Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women Academic Article
-
Comparison of anticoagulation with left atrial appendage closure after atrial fibrillation ablation: Rationale and design of the OPTION randomized trial Academic Article
-
Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial Academic Article
-
Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)‐5 trial Academic Article
-
Comparison of the effect of coagulation and platelet function impairments on various mouse bleeding models Academic Article
-
Comparison of the haemorrhagic effects of porcine and bovine heparin in rabbits Academic Article
-
Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-iii affinity heparin fraction Academic Article
-
Comparison of three‐factor and four‐factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers Academic Article
-
Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II Academic Article
-
Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial Academic Article
-
Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting Academic Article
-
Continuous intravenous infusion of a plasma-derived factor IX concentrate (Mononine®
) in haemophilia B Academic Article
-
Control of Severe, Life-Threatening External Bleeding in the Out-of-Hospital Setting: A Systematic Review Academic Article
-
Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist Academic Article
-
Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden Academic Article
-
Cost‐utility analysis of emicizumab for the treatment of severe hemophilia A patients in Canada Academic Article
-
Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura Academic Article
-
D-Dimer Assays in Diagnosis and Management of Thrombotic and Bleeding Disorders Academic Article
-
DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines Academic Article
-
DOAC–associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature Academic Article
-
Dabigatran Etexilate: Future Directions in Anticoagulant Treatment Academic Article
-
Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery Academic Article
-
Dabigatran Reversal With Idarucizumab in Patients With Renal Impairment Academic Article
-
Dabigatran Versus Warfarin in Patients With Atrial Fibrillation Academic Article
-
Dabigatran etexilate for prevention of venous thromboembolism Academic Article
-
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial Academic Article
-
Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve‐Induced Thrombin Generation Academic Article
-
Dabigatran monitoring made simple? Academic Article
-
Dabigatran reversal by idarucizumab in the setting of intracranial hemorrhage: A systematic review of the literature Academic Article
-
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II. Academic Article
-
Dabigatran versus Warfarin in Patients with Atrial Fibrillation Academic Article
-
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves Academic Article
-
Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency Academic Article
-
Dalteparin versus Unfractionated Heparin in Critically Ill Patients Academic Article
-
Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3) Academic Article
-
Death of a Child From Topical Diphenhydramine Academic Article
-
Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009) Academic Article
-
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention Academic Article
-
Defining high bleeding risk in patients undergoing percutaneous coronary
intervention: a consensus document from the Academic Research Consortium for High Bleeding
Risk Academic Article
-
Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology Academic Article
-
Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH Academic Article
-
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients Academic Article
-
Definition of major bleeding used by US anticoagulation clinics Academic Article
-
Delayed intracranial hemorrhage after head injury among elderly patients on anticoagulation seen in the emergency department Academic Article
-
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) Academic Article
-
Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran Academic Article
-
Design and rationale of CURRENT-OASIS 7: A randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non–ST-elevation acute coronary syndromes managed with an early invasive strategy Academic Article
-
Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy Academic Article
-
Determinants of Bleeding Risk in Patients on Antithrombotic and Antifibrinolytic Drugs Academic Article
-
Determinants of myocardial hemorrhage after coronary reperfusion in the anesthetized dog. Academic Article
-
Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin Academic Article
-
Diagnosis and Management of Mild Bleeding Disorders Academic Article
-
Diagnosis and Management of Neonatal Alloimmune Thrombocytopenia Academic Article
-
Diagnosis of DVT Academic Article
-
Diagnostic Yield and Complication Rate in Percutaneous Needle Biopsy of Renal Hilar Masses With Comparison With Renal Cortical Mass Biopsies in a Cohort of 195 Patients Academic Article
-
Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study Commentary: Varied preferences reflect the reality of clinical practice Academic Article
-
Differences in the safety profiles of two low-molecular-weight heparins Academic Article
-
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis Academic Article
-
Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation Academic Article
-
Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding Academic Article
-
Direct Oral Anticoagulants Academic Article
-
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis Academic Article
-
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies Academic Article
-
Direct oral anticoagulants Academic Article
-
Direct oral anticoagulants after bariatric surgery—What is the evidence? Academic Article
-
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Academic Article
-
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis Academic Article
-
Direct oral anticoagulants: evidence and unresolved issues Academic Article
-
Direct thrombin inhibitors in cardiovascular disease Academic Article
-
Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction? Academic Article
-
Does Statin Therapy Decrease the Risk for Bleeding in Patients Who Are Receiving Warfarin? Academic Article
-
Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes Academic Article
-
Dose-Response Study of Recombinant Factor VIIa/Tissue Factor Inhibitor Recombinant Nematode Anticoagulant Protein c2 in Prevention of Postoperative Venous Thromboembolism in Patients Undergoing Total Knee Replacement Academic Article
-
Dose–response study of recombinant human soluble thrombomodulin (ART‐123) in the prevention of venous thromboembolism after total hip replacement Academic Article
-
Dosing Practices and Risk Factors for Bleeding in Patients Receiving Enoxaparin for the Treatment of an Acute Coronary Syndrome Academic Article
-
Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention Academic Article
-
Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review Academic Article
-
Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Academic Article
-
Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence Academic Article
-
Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: A position statement of the Canadian Cardiovascular Society Academic Article
-
Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH Academic Article
-
Duration of anticoagulant therapy after first episode of venous thrombosis in patients with inherited thrombophilia Academic Article
-
Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism Academic Article
-
Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation Academic Article
-
Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes Academic Article
-
Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy Academic Article
-
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism Academic Article
-
Edoxaban for treatment of venous thromboembolism in patients with cancer Academic Article
-
Edoxaban versus Warfarin in Patients with Atrial Fibrillation Academic Article
-
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial Academic Article
-
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism Academic Article
-
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation Academic Article
-
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty Academic Article
-
Effect of extended‐duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis Academic Article
-
Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure Academic Article
-
Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events Academic Article
-
Effectiveness and safety of abciximab after failed thrombolytic therapy Academic Article
-
Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min Academic Article
-
Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism Academic Article
-
Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism Academic Article
-
Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1 Academic Article
-
Effectiveness of Anticoagulants Academic Article
-
Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction11Guest Editor for this manuscript was Peter B. Berger, MD, Mayo Clinic, Rochester, Minn. Academic Article
-
Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes Academic Article
-
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation Academic Article
-
Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial Academic Article
-
Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation Academic Article
-
Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study Academic Article
-
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding Academic Article
-
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension. Academic Article
-
Effects of changes in topographical distribution of lung blood flow on gas exchange Academic Article
-
Effects of dabigatran according to age in atrial fibrillation Academic Article
-
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment Academic Article
-
Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial Academic Article
-
Effects of sodium warfarin administered during pregnancy in mice Academic Article
-
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) A randomised, placebo-controlled trial. Academic Article
-
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial Academic Article
-
Effects ofCYP2C19Genotype on Outcomes of Clopidogrel Treatment Academic Article
-
Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials Academic Article
-
Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis: comment Academic Article
-
Efficacy and Safety of Dabigatran Etexilate vs. Warfarin in Asian RE-LY Patients According to Baseline Renal Function or CHADS<sub>2</sub> Score Academic Article
-
Efficacy and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation - Sub-Analysis in Japanese Population in RE-LY Trial - Academic Article
-
Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism Academic Article
-
Efficacy and Safety of the Factor VIII/von Willebrand Factor Concentrate, Haemate-P/Humate-P: Ristocetin Cofactor Unit Dosing in Patients with von Willebrand Disease Academic Article
-
Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial Academic Article
-
Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial Academic Article
-
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Academic Article
-
Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement Academic Article
-
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial Academic Article
-
Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves Academic Article
-
Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease Academic Article
-
Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a “CASPAR like” outcome from VOYAGER PAD Academic Article
-
Efficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric surgery: A systematic review and meta-analysis Academic Article
-
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™ Academic Article
-
Efficacy of high dose tranexamic acid (TXA) for hemorrhage: A systematic review and meta-analysis Academic Article
-
Electron microscopy examination of platelet whole mount preparations to quantitate platelet dense granule numbers: Implications for diagnosing suspected platelet function disorders due to dense granule deficiency Academic Article
-
Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants Academic Article
-
Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction Academic Article
-
Enoxaparin Use in the Neonatal Intensive Care Unit: Experience Over 8 Years Academic Article
-
Enoxaparin Versus Dabigatran or Rivaroxaban for Thromboprophylaxis After Hip or Knee Arthroplasty Academic Article
-
Enoxaparin versus Unfractionated Heparin in ST-Elevation Myocardial Infarction Academic Article
-
Establishing an Optimal Therapeutic Range for Coumarins Academic Article
-
Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial Academic Article
-
Ethnoracial variations in venous thrombosis: Implications for management, and a call to action Academic Article
-
Evaluating Hemorrhage in Renal Cell Carcinoma Using Susceptibility Weighted Imaging Academic Article
-
Evaluating coagulation tests in patients with atrial fibrillation using direct oral anticoagulants Academic Article
-
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis Academic Article
-
Evaluation of T1-Weighted MRI to Detect Intratumoral Hemorrhage Within Papillary Renal Cell Carcinoma as a Feature Differentiating From Angiomyolipoma Without Visible Fat Academic Article
-
Evaluation of patients’ attitudes towards stroke prevention and bleeding risk in atrial fibrillation Academic Article
-
Evaluation of safety and effectiveness of factor VIII treatment in haemophilia A patients with low titre inhibitors or a personal history of inhibitor Academic Article
-
Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas Academic Article
-
Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study Academic Article
-
Evidence-Based Management of Anticoagulant Therapy Academic Article
-
Evidence-Based Minireview: Mortality and thrombosis in patients receiving prothrombin complex concentrates or andexanet alfa for the management of direct oral factor Xa inhibitor–associated major bleeding Academic Article
-
Experiences of a low-intensity anticoagulation regimen for extended secondary prevention of venous thromboembolism Academic Article
-
Experiences with continuous infusion of recombinant activated factor VII. Conference Paper
-
Expert Approaches to Common Bleeding and Thrombotic Problems, Part II Academic Article
-
Expert Approaches to Common Bleeding and Thrombotic Problems—Part I Academic Article
-
Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy Academic Article
-
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients Academic Article
-
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism Academic Article
-
Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study Academic Article
-
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study Academic Article
-
Extended perioperative thromboprophylaxis in patients with cancer. A systematic review. Academic Article
-
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post‐hoc analysis of the Hokusai‐VTE Cancer study Academic Article
-
Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility Academic Article
-
Extended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients: a systematic review and meta-analysis of randomized controlled trials Academic Article
-
Extension of anticoagulation after venous thromboembolism Academic Article
-
Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials Academic Article
-
Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene Academic Article
-
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis Academic Article
-
Factor XI inhibitors: cardiovascular perspectives Academic Article
-
Factor XI inhibitors: what should clinicians know Academic Article
-
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial Academic Article
-
Factors Associated With Adverse Outcomes in Outpatients Presenting With Pulmonary Embolism Academic Article
-
Factors and inhibitors of blood coagulation and fibrinolysis in acute nonlymphoblastic leukaemia Academic Article
-
Factors at Admission Associated With Bleeding Risk in Medical Patients Academic Article
-
Failure to correct International Normalized Ratio and mortality among patients with warfarin‐related major bleeding: an analysis of electronic health records Academic Article
-
Feasibility and safety of delivering full-dose anticoagulation therapy in children treated according to Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium therapy protocols Academic Article
-
Fetal Effects of Coumadin Administered During Pregnancy Academic Article
-
First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study Academic Article
-
First-Line Therapy for Immune Thrombocytopenia Academic Article
-
Fish Oils and Low-Molecular-Weight Heparin for the Reduction of Restenosis After Percutaneous Transluminal Coronary Angioplasty Academic Article
-
Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control Academic Article
-
Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy Academic Article
-
Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery Academic Article
-
Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery Academic Article
-
Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: Outcomes and treatment effect across different levels of risk Academic Article
-
Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs Academic Article
-
Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score–matched study Academic Article
-
Fondaparinux in the management of patients with ST-elevation acute myocardial infarction Academic Article
-
Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6 Academic Article
-
Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT) – Bridging the River Coumarin Academic Article
-
Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding Academic Article
-
Frequency and Predictors of Major Bleeding in Patients With Embolic Strokes of Undetermined Source Academic Article
-
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors Academic Article
-
G-Protein–Coupled Receptors as Signaling Targets for Antiplatelet Therapy Academic Article
-
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation Academic Article
-
Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding Academic Article
-
Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudy Academic Article
-
Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation Academic Article
-
Global Prospective Safety Analysis of Rivaroxaban Academic Article
-
Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial Academic Article
-
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors Academic Article
-
Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation. Academic Article
-
Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU Academic Article
-
HEPARIN IN THE TREATMENT OF VENOUS THROMBOEMBOLIC DISEASE: ADMINISTRATION, CONTROL AND RESULTS Academic Article
-
Haemophilia Experiences, Results and Opportunities (HERO) study: treatment-related characteristics of the population Academic Article
-
Haemophilia prophylaxis: how can we justify the costs? Academic Article
-
Haemorrhagic and thromboembolic complications versus intensity of treatment of venous thromboembolism with oral anticoagulants. Academic Article
-
Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin Academic Article
-
Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding Academic Article
-
Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study Academic Article
-
Hemodialysis Patients' Satisfaction and Perspectives on Complications associated with Vascular Access Related Interventions: Are We Listening? Academic Article
-
Hemodialysis for the treatment of dabigatran‐associated bleeding: a case report and systematic review Academic Article
-
Hemorrhage After Auricular Acupuncture due to Postoperative Dilutional Thrombocytopenia Academic Article
-
Hemorrhagic Complications in Pediatric Hematologic Malignancies Academic Article
-
Hemorrhagic Complications of Anticoagulant Therapy Academic Article
-
Hemorrhagic Complications of Anticoagulant Treatment Academic Article
-
Hemorrhagic Complications of Anticoagulant Treatment Academic Article
-
Hemorrhagic Complications of Anticoagulant Treatment Academic Article
-
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment Academic Article
-
Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism Academic Article
-
Hemorrhagic complications in association with percutaneous coronary intervention: can the risk be attenuated? Academic Article
-
Hemorrhagic complications of anticoagulant treatment. Academic Article
-
Hemorrhagic complications of anticoagulant treatment. Academic Article
-
Hemorrhagic complications of long-term anticoagulant therapy for ischemic cerebral vascular disease. Academic Article
-
Hemorrhagic complications of long-term anticoagulant therapy. Academic Article
-
Hemorrhagic complications of long-term anticoagulant therapy. Academic Article
-
Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. Academic Article
-
Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. Academic Article
-
Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect Academic Article
-
Heparin and Graduated Compression Stockings in Patients Academic Article
-
Heparin and Low-Molecular-Weight Heparin Academic Article
-
Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis Academic Article
-
Heparin induced bleeding. Academic Article
-
Heparin-Induced Thrombocytopenia Presenting as Bilateral Adrenal Hemorrhages Academic Article
-
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Academic Article
-
Hepatic Interstitial Laser Photocoagulation An Investigation of the Relationship between Acute Thermal Lesions and their Sonographic Images Academic Article
-
High adherence to prophylaxis regimens in haemophilia B patients receiving rIX‐FP: Evidence from clinical trials and real‐world practice Academic Article
-
Hirudin and thrombosis prophylaxis Academic Article
-
Home-monitoring of oral anticoagulation vs. dabigatran Academic Article
-
Hospitalization for Hemorrhage Among Warfarin Recipients Prescribed Amiodarone Academic Article
-
How Did We Get Here?: A Historical Review and Critical Analysis of Anticoagulation Therapy Following Mechanical Valve Replacement Academic Article
-
How I investigate for bleeding disorders Academic Article
-
How I treat target-specific oral anticoagulant–associated bleeding Academic Article
-
How can we reverse bleeding in patients on direct oral anticoagulants? Academic Article
-
How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa. Conference Paper
-
How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society Academic Article
-
How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice Academic Article
-
ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders Academic Article
-
Iatrogenic Adverse Events in the Coronary Care Unit Academic Article
-
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study Academic Article
-
Idarucizumab Academic Article
-
Idarucizumab for Dabigatran Reversal Academic Article
-
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis Academic Article
-
Identified unmet needs and proposed solutions in mild‐to‐moderate haemophilia: A summary of opinions from a roundtable of haemophilia experts Academic Article
-
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments] Academic Article
-
Imaging of stroke: a comparison between X-ray fluorescence and magnetic resonance imaging methods Academic Article
-
Immune thrombocytopenia (
ITP
)
World Impact Survey
(
I‐WISh
): Impact of
ITP
on health‐related quality of life Academic Article
-
Immunological Consequences of Topical Bovine Thrombin Academic Article
-
Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting Academic Article
-
Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease Academic Article
-
Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban Academic Article
-
Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial Academic Article
-
Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients Academic Article
-
Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a post hoc analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial Academic Article
-
Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction Academic Article
-
Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement Academic Article
-
Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes Academic Article
-
Improved platelet counts during prolonged tranexamic therapy for Quebec platelet disorder implicate the underlying fibrinolytic defect as the cause of lower platelet counts Academic Article
-
Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation Academic Article
-
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes Academic Article
-
In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleeding Academic Article
-
In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets Academic Article
-
In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS2and CHA2DS2-VASc Academic Article
-
In patients receiving DAPT after coronary stents, the PRECISE-DAPT score predicted bleeding moderately well Academic Article
-
In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding Academic Article
-
In vivo Effects of Low Molecular Weight Heparins on Experimental Thrombosis and Bleeding Academic Article
-
Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy Academic Article
-
Incidence and predictors of splanchnic vein thrombosis and mortality following hepatobiliary and pancreatic surgery Academic Article
-
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis Academic Article
-
Indirect comparisons of efficacy and weekly factor consumption during continuous prophylaxis with recombinant factor VIII Fc fusion protein and conventional recombinant factor VIII products Academic Article
-
Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation Academic Article
-
Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention Academic Article
-
Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in Non–ST-Segment Elevation Acute Coronary Syndromes Academic Article
-
Influence of activated factor VII concentrates on thrombin generation in full-term and preterm neonates Academic Article
-
Influence of low-intensity warfarin treatment on patients' perceptions of quality of life Academic Article
-
Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome Academic Article
-
Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction Academic Article
-
Inotropes, vasopressors, and mechanical circulatory support for treatment of cardiogenic shock complicating myocardial infarction: a systematic review and network meta-analysis Academic Article
-
Integrating Frailty Assessment Into Cardiovascular Decision Making Academic Article
-
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation Academic Article
-
International Normalized Ratio Targets for Left-Sided Mechanical Valve Replacement Academic Article
-
International assessment of massive transfusion protocol contents and indications for activation Academic Article
-
Intracranial and fatal bleeding according to indication for long‐term oral anticoagulant therapy Academic Article
-
Is Heparin the Ideal Anticoagulant for Cardiopulmonary Bypass? Dermatan Sulphate May Be an Alternate Choice Academic Article
-
Is aspirin safer than a direct oral anticoagulant for patients with atrial fibrillation at high risk of bleeding? Academic Article
-
Is there really misuse and abuse of dabigatran? Academic Article
-
Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48 Academic Article
-
Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy Academic Article
-
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation Academic Article
-
LMW Heparin for Deep Vein Thrombosis Academic Article
-
Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation Academic Article
-
Lack of Relationship Between Enhanced Bleeding Induced by Heparin and Other Sulfated Polysaccharides and Enhanced Catalysis of Thrombin Inhibition Academic Article
-
Lack of consistency in the relationship between asymptomatic DVT detected by venography and symptomatic VTE in thromboprophylaxis trials Academic Article
-
Left Atrial Appendage Occlusion Academic Article
-
Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials Academic Article
-
Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia Academic Article
-
Letter to the Editor Academic Article
-
Life-threatening lingual artery hemorrhage after cardiac surgery Academic Article
-
Limited Fibrin Specificity of Tissue-type Plasminogen Activator and Its Potential Link to Bleeding Academic Article
-
Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial Academic Article
-
Local venous infusion of streptokinase in DVT Academic Article
-
Long-Term Effects of Indomethacin Prophylaxis in Extremely-Low-Birth-Weight Infants Academic Article
-
Long-Term Management of Venous Thromboembolism: Lessons from EINSTEIN CHOICE and Other Extension Trials Academic Article
-
Long-Term Oral Anticoagulant Therapy in Patients With Unstable Angina or Suspected Non–Q-Wave Myocardial Infarction Academic Article
-
Long-Term Prophylaxis in Venous Thromboembolism: LMWH or Oral Anticoagulation? Conference Paper
-
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism Academic Article
-
Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis Academic Article
-
Long-Term Treatment with Apixaban in Patients with Atrial Fibrillation: Outcomes during the Open-Label Extension following AVERROES Academic Article
-
Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children Academic Article
-
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis Academic Article
-
Long-term risk of adverse outcomes according to atrial fibrillation type Academic Article
-
Long-term use of left ventricular assist devices: a report on clinical outcomes Academic Article
-
Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement Academic Article
-
Low Molecular Weight Heparin Administered once versus twice Daily in Patients with Venous Thromboembolism Academic Article
-
Low Molecular Weight Heparin and Compression Stockings in the Prevention of Venous Thromboembolism in Neurosurgery Academic Article
-
Low Molecular Weight Heparins (LMWH) in the Treatment of Patients with Acute Venous Thromboembolism Conference Paper
-
Low PAI-1 activity in relation to inflammatory parameters, insulin profile and body mass index Academic Article
-
Low PAI-1 activity in relation to the risk for perioperative bleeding complications in transurethral resection of the prostate Academic Article
-
Low molecular weight heparin Academic Article
-
Low molecular weight heparin and bleeding in patients with chronic renal failure Academic Article
-
Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer Academic Article
-
Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer Academic Article
-
Low molecular weight heparin: a critical analysis of clinical trials. Academic Article
-
Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism Academic Article
-
Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux: The FUTURA/OASIS-8 Randomized Trial Academic Article
-
Low-Intensity versus Conventional-Intensity Warfarin for Prevention of Recurrent Venous Thromboembolism Academic Article
-
Low-Molecular-Weight Heparin Compared with Intravenous Unfractionated Heparin for Treatment of Pulmonary Embolism Academic Article
-
Low-Molecular-Weight Heparin and Cancer Survival: Review of the Literature and Pooled Analysis of 1,726 Patients Treated for at Least Three Months Academic Article
-
Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism Academic Article
-
Low-Molecular-Weight Heparin or Oral Anticoagulation for Secondary Prevention of Deep Vein Thrombosis in Cancer Patients Academic Article
-
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer Academic Article
-
Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial Academic Article
-
Low-Molecular-Weight and Unfractionated Heparin for Prevention of Venous Thromboembolism in Neurosurgery Academic Article
-
Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review Academic Article
-
Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials Academic Article
-
Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial Academic Article
-
Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants Academic Article
-
Low-molecular-weight heparin in patients with chronic renal insufficiency Academic Article
-
Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: A systematic review Academic Article
-
Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Academic Article
-
Magnitude of and Risk Factors for In-Hospital and Postdischarge Stroke in Patients With Acute Coronary Syndromes Academic Article
-
Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin Academic Article
-
Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials Academic Article
-
Major bleeding risk with warfarin for deep vein thrombosis. Academic Article
-
Management Of Venous Thromboembolism: Optimization By Clinical Trials Academic Article
-
Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin Academic Article
-
Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting Academic Article
-
Management of Anticoagulation before and after Elective Surgery Academic Article
-
Management of Bleeding Complications in the Anticoagulated Patient Academic Article
-
Management of Bleeding in Patients Receiving Conventional or New Anticoagulants Academic Article
-
Management of Bleeding in Patients with Advanced Cancer Academic Article
-
Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy Academic Article
-
Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures Academic Article
-
Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures Academic Article
-
Management of bleeding complications in patients with cancer on DOACs Academic Article
-
Management of bleeding in patients on antithrombotics: maintaining the balance between thrombosis and hemorrhage Academic Article
-
Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease Academic Article
-
Management of bleeding with oral anticoagulants in patients with atrial fibrillation Academic Article
-
Management of direct factor Xa inhibitor–related major bleeding with prothrombin complex concentrate: a meta-analysis Academic Article
-
Management of direct oral anticoagulant associated bleeding: Results of a multinational survey Academic Article
-
Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses Academic Article
-
Management of intentional overdose of low-molecular-weight heparin Academic Article
-
Management of major bleeds in patients with immune thrombocytopenia Academic Article
-
Management of new oral anticoagulants related life threatening or major bleedings in real life: a brief report Academic Article
-
Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study Academic Article
-
Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting Academic Article
-
Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents Conference Paper
-
Managing oral anticoagulant therapy. Academic Article
-
Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents Academic Article
-
Mandatory contrast-enhanced venography to detect deep-vein thrombosis (DVT) in studies of DVT prophylaxis: upsides and downsides Academic Article
-
Marijuana Use Academic Article
-
Massive hemorrhage protocol survey: Marked variability and absent in one-third of hospitals in Ontario, Canada Academic Article
-
Maternal and neonatal outcomes in planned versus emergency cesarean delivery for placenta accreta spectrum: A multinational database study Academic Article
-
Measuring Dabigatran Levels: What Tests Are Available and What Still Needs to Be Done? Academic Article
-
Mechanical valves Academic Article
-
Mechanical versus bioprosthetic valves in chronic dialysis: a systematic review and meta-analysis Academic Article
-
Meta-Analysis of Continuous Oral Anticoagulants Versus Heparin Bridging in Patients Undergoing CIED Surgery: Reappraisal after the BRUISE Study Academic Article
-
Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency Academic Article
-
Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients Academic Article
-
Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies Academic Article
-
Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers Academic Article
-
Methods of Administering Superimposed High-Frequency Jet Ventilation and the Associated Risk for Aspiration in a Model of Tracheal Bleeding Academic Article
-
Miconazole Oral Gel Potentiates Warfarin Anticoagulant Activity Academic Article
-
Minimizing costs for treating deep vein thrombosis: the role for fondaparinux Academic Article
-
Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS
2
and CHA
2
DS
2
-VASc Scores in Patients With Atrial Fibrillation Academic Article
-
Molecular phenotype and bleeding risks of an inherited platelet disorder in a family with a RUNX1
frameshift mutation Academic Article
-
Monitoring Emerging Data From the COMPASS Trial of an Antithrombotic Agent Academic Article
-
Monitoring and reversal of direct oral anticoagulants Academic Article
-
Monoclonal Purified F VIII for Continuous Infusion: Stability, Microbiological Safety and Clinical Experience Academic Article
-
More on Acutely Injured Patients Receiving Dabigatran Academic Article
-
Morphological abnormalities during early-life development of the estuarine mummichog, Fundulus heteroclitus, as an indicator of androgenic and anti-androgenic endocrine disruption Academic Article
-
Mortality and morbidity following a major bleed in a registry population with acute ST elevation myocardial infarction Academic Article
-
Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials Academic Article
-
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W Academic Article
-
Multicenter Randomized Controlled Trial of Terlipressin Versus Sclerotherapy in the Treatment of Acute Variceal Bleeding: The TEST Study Academic Article
-
Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding Academic Article
-
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids‐DOTT trial): pilot/feasibility phase findings Academic Article
-
Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia Academic Article
-
Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation Academic Article
-
Mutation Analysis in F9 Gene of 17 Families with Haemophilia B from Iran Conference Paper
-
Myocardial injury after non-cardiac surgery: diagnosis and management Academic Article
-
Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable Academic Article
-
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER®, RE-COVER™ II, and RE-MEDY™ Academic Article
-
Neutralization of Enoxaparine-lnduced Bleeding by Protamine Sulfate Academic Article
-
New Anti-thrombotic Agents: Emphasis on Hemorrhagic Complications and Their Management Conference Paper
-
New Strategies for the Optimal Use of Platelet Transfusions Academic Article
-
New anticoagulants: Moving beyond the direct oral anticoagulants Academic Article
-
New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF Academic Article
-
New oral anticoagulant agents – general features and outcomes in subsets of patients Academic Article
-
New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty Academic Article
-
New oral anticoagulants in development Academic Article
-
New-Onset Atrial Fibrillation Academic Article
-
Newly Identified Events in the RE-LY Trial Academic Article
-
Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats Academic Article
-
Noninvasive Diagnosis of Pulmonary Hemorrhage in Rheumatoid Arthritis Academic Article
-
Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment Academic Article
-
North American Thrombosis Forum, AF Action Initiative Consensus Document Academic Article
-
Novel Oral Anticoagulants and the Risk of Major Hemorrhage in Elderly Patients With Chronic Kidney Disease: A Nested Case-Control Study Academic Article
-
Novel bleeding risk score for patients with atrial fibrillation on oral anticoagulants, including direct oral anticoagulants Academic Article
-
Novel oral anticoagulants and reversal agents: Considerations for clinical development Academic Article
-
Novel platelet products, substitutes and alternatives Academic Article
-
ON THE BLEEDER: A CASE OF VON WILLEBRAND'S DISEASE AND ITS TREATMENT WITH HUMAN ANTI-HAEMOPHILIC FACTOR. Academic Article
-
ON THE BLEEDER: A CASE OF VON WILLEBRAND'S DISEASE AND ITS TREATMENT WITH HUMAN ANTI‐HÆMOPHILIC FACTOR Academic Article
-
Off-label use of recombinant activated factor VII in surgical and non-surgical patients at 16 Canadian hospitals from 2007 to 2010 (Canadian Registry Report) Academic Article
-
On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome Academic Article
-
Optimal Duration of Anticoagulant Therapy Academic Article
-
Optimal Duration of Oral Anticoagulant Therapy in Venous Thromboembolism Academic Article
-
Optimal intensity and monitoring warfarin Academic Article
-
Optimal reversal of vitamin K antagonists Academic Article
-
Oral Anticoagulant Use in Patients with Morbid Obesity: A Systematic Review and Meta-Analysis Academic Article
-
Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease Academic Article
-
Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation Academic Article
-
Oral Anticoagulation Treatment in the Elderly Academic Article
-
Oral Apixaban for the Treatment of Acute Venous Thromboembolism Academic Article
-
Oral Corticosteroid Therapy as an Adjuvant Treatment for Acute Bleeding in Hemophilia Patients With High Titer Inhibitors Academic Article
-
Oral Rivaroxaban for Symptomatic Venous Thromboembolism Academic Article
-
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism Academic Article
-
Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin Academic Article
-
Oral anticoagulant use in addition to antiplatelet therapy for secondary prevention in acute coronary syndrome: current perspectives Academic Article
-
Oral anticoagulants in patients with coronary artery disease Academic Article
-
Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks Academic Article
-
Oral anticoagulation for prolonging survival in patients with cancer Academic Article
-
Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Oral anticoagulation in venous thromboembolism: decisions based on more than mere feelings Academic Article
-
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial Academic Article
-
Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis Academic Article
-
Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement Academic Article
-
Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10 Academic Article
-
Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials Academic Article
-
Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS study Academic Article
-
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy Academic Article
-
Outcomes associated with non-recommended dosing of rivaroxaban: results from the XANTUS study Academic Article
-
Outcomes for studies assessing the efficacy of hemostatic therapies in persons with congenital bleeding disorders Academic Article
-
Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF Academic Article
-
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study Academic Article
-
Overview of the clinical results of pentasaccharide in major orthopedic surgery. Academic Article
-
Palliative Management of Bleeding Events in Advanced Cancer Patients Academic Article
-
Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation Academic Article
-
Parenteral anticoagulation in ambulatory patients with cancer Academic Article
-
Parenteral anticoagulation in ambulatory patients with cancer Academic Article
-
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Paroxysmal Atrial Fibrillation in a Patient on Hemodialysis Academic Article
-
Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study Academic Article
-
Patient data meta‐analysis of Post‐Authorization Safety Surveillance (PASS) studies of haemophilia A patients treated with
rAHF
‐PFM Academic Article
-
Patient outcomes using the European label for dabigatran Academic Article
-
Patient preferences and priorities for haemophilia gene therapy in the US: A discrete choice experiment Academic Article
-
Patient preferences for venous thromboembolism prophylaxis after injury: a discrete choice experiment Academic Article
-
Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry Academic Article
-
Patients with Peripheral Artery Disease in the COMPASS Trial Academic Article
-
Patterns of joint damage in severe haemophilia A treated with prophylaxis Academic Article
-
Patterns of tertiary prophylaxis in Canadian adults with severe and moderately severe haemophilia B Academic Article
-
Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial Academic Article
-
Perioperative Aspirin and Clonidine and Risk of Acute Kidney Injury Academic Article
-
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation Academic Article
-
Perioperative Evaluation of Bleeding Diathesis Academic Article
-
Perioperative Management of Antiplatelet Therapy in Patients With a Coronary Stent Who Need Noncardiac Surgery Academic Article
-
Perioperative Management of Dabigatran Academic Article
-
Perioperative Management of the Direct Oral Anticoagulants Academic Article
-
Perioperative management of antithrombotic therapy: a case-based narrative review Academic Article
-
Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach Academic Article
-
Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin Academic Article
-
Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists Academic Article
-
Periprocedural Management of Oral Anticoagulation Academic Article
-
Periprocedural Management of Oral Anticoagulation in Patients With Atrial Fibrillation: Approach in the Era of New Oral Anticoagulants Academic Article
-
Periprocedural anticoagulation practices in warfarin-treated patients who require elective angiography with or without percutaneous coronary intervention: A retrospective chart review Academic Article
-
Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH Academic Article
-
Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy Academic Article
-
Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery Academic Article
-
Periprocedural risk of bleeding and thrombosis: to bridge or not to bridge. Dr. James Douketis in an interview with Dr. Roman Jaeschke: part 2 Academic Article
-
Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTH Academic Article
-
Pharmacologic tools to reduce bleeding in surgery. Academic Article
-
Pharmacological Actions of Sulodexide Academic Article
-
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis Academic Article
-
Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral–Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial Academic Article
-
Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome Academic Article
-
Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation. Academic Article
-
Plasma and Plasma Protein Product Transfusion: A Canadian Blood Services Centre for Innovation Symposium Academic Article
-
Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities Academic Article
-
Plasma transfusion practices: A multicentre electronic audit Academic Article
-
Plasma transfusion trials and tribulations Academic Article
-
Plasma versus prothrombin complex concentrate for warfarin-associated major bleeding: a systematic review Academic Article
-
Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry Academic Article
-
Platelet count or bleeding as the outcome in ITP trials? Academic Article
-
Platelet factor V New York: A defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation Academic Article
-
Platelet function analyzer (PFA)‐100® closure time in the evaluation of platelet disorders and platelet function Academic Article
-
Point-of-Care Hemostatic Testing in Cardiac Surgery Academic Article
-
Positioning new treatments in the management of immune thrombocytopenia Academic Article
-
Possible Influence of Stroke Etiology on Hemorrhagic Transformation Following Thrombolysis in Warfarin-Treated Patients Academic Article
-
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients Academic Article
-
Potential antidotes for reversal of old and new oral anticoagulants Academic Article
-
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation Academic Article
-
Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk Academic Article
-
Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure Conference Paper
-
Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban Academic Article
-
Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants Academic Article
-
Practical management of coagulopathy associated with warfarin. Academic Article
-
Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation Academic Article
-
Praktische Behandlung der Warfarin-assoziierten Gerinnungsstörung Academic Article
-
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Academic Article
-
Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol Academic Article
-
Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study Academic Article
-
Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study Academic Article
-
Predictors of Mortality in Patients With Lacunar Stroke in the Secondary Prevention of Small Subcortical Strokes Trial Academic Article
-
Predictors of bleeding complications following percutaneous image-guided liver biopsy: a scoping review Academic Article
-
Prenatal Diagnosis of Genetic Disorders: Trials and Tribulations Academic Article
-
Preoperative prediction of Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study Academic Article
-
Preperitoneal packing for pelvic fracture-associated hemorrhage: A systematic review, meta-analysis, and practice management guideline from the Eastern Association for the Surgery of Trauma Academic Article
-
Prevalence and correlates of bleeding and emotional harms in a national US sample of patients with venous thromboembolism: A cross-sectional structural equation model Academic Article
-
Prevalence and risk of inappropriate dosing of direct oral anticoagulants in two Swiss atrial fibrillation registries Academic Article
-
Preventing Cardioembolic Stroke in Atrial Fibrillation with Dabigatran Academic Article
-
Preventing and managing bleeding complications in anticoagulated patients: A case based approach Academic Article
-
Prevention and 18-Month Outcomes of Serious Pulmonary Hemorrhage in Extremely Low Birth Weight Infants: Results From the Trial of Indomethacin Prophylaxis in Preterms Academic Article
-
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention Academic Article
-
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment Academic Article
-
Prevention of Deep Vein Thrombosis after Elective Hip Surgery Academic Article
-
Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator Academic Article
-
Prevention of Postthrombotic Syndrome Academic Article
-
Prevention of VTE in Orthopedic Surgery Patients Academic Article
-
Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines Academic Article
-
Prevention of Vascular Events in Patients with Atrial Fibrillation: Academic Article
-
Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial Academic Article
-
Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation Academic Article
-
Prevention of venous thrombosis with small, subcutaneous doses of heparin Academic Article
-
Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized Academic Article
-
Pro: “Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation” Academic Article
-
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation Academic Article
-
Prognostic Significance of Thrombocytopenia During Hirudin and Heparin Therapy in Acute Coronary Syndrome Without ST Elevation Academic Article
-
Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis Academic Article
-
Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran Academic Article
-
Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation Academic Article
-
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation Academic Article
-
Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature Academic Article
-
Prothrombin complex concentrate (PCC, Octaplex®) in patients requiring immediate reversal of vitamin K antagonist anticoagulation Academic Article
-
Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis Academic Article
-
Prothrombin, alone or in complex concentrates or plasma, reduces bleeding in a mouse model of blood exchange-induced coagulopathy Academic Article
-
Protocol for a multicentre, randomised, parallel-control, superiority trial comparing administration of clotting factor concentrates with a standard massive haemorrhage protocol in severely bleeding trauma patients: the FiiRST 2 trial (a 2020 EAST multicentre trial) Academic Article
-
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry Academic Article
-
Quality of individual INR control and the risk of stroke and bleeding events in atrial fibrillation patients: A nested case control analysis of the ACTIVE W study Academic Article
-
Quality of oral anticoagulant control and treatment in Sweden. Duration of Anticoagulation (DURAC) Trial Study Group. Academic Article
-
Quantitative Susceptibility Mapping for Characterization of Intraplaque Hemorrhage and Calcification in Carotid Atherosclerotic Disease Academic Article
-
Quebec Platelet Disorder: Update on Pathogenesis, Diagnosis, and Treatment Academic Article
-
Quebec platelet disorder Academic Article
-
RANDOMISED COMPARISON OF TWO INTENSITIES OF ORAL ANTICOAGULANT THERAPY AFTER TISSUE HEART VALVE REPLACEMENT Academic Article
-
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate Academic Article
-
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome Academic Article
-
Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease Academic Article
-
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial Academic Article
-
Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials Academic Article
-
Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation Academic Article
-
Randomized Trial of Compression Duration After Transradial Cardiac Catheterization and Intervention Academic Article
-
Randomized phase 2 trial comparing JNJ‐9375, a thrombin‐directed antibody, with apixaban for prevention of venous thrombosis Academic Article
-
Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention Academic Article
-
Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients Academic Article
-
Rates of hemorrhage during warfarin therapy for atrial fibrillation Academic Article
-
Rationale Behind the Development of Low Molecular Weight Heparin Derivatives Academic Article
-
Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment Academic Article
-
Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery Academic Article
-
Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention Academic Article
-
Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens Academic Article
-
Real-world management and outcomes of 7 million patients with acute coronary syndrome according to clinical research trial enrolment status: a propensity matched analysis Academic Article
-
Real-world vs. randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKET AF and XANTUS Academic Article
-
Real‐world variability in dabigatran levels in patients with atrial fibrillation Academic Article
-
Reanimating Patients After Traumatic Cardiac Arrest Academic Article
-
Recent Advances in Antidotes for Direct Oral Anticoagulants: Their Arrival Is Imminent Academic Article
-
Recombinant FVIIa in children with liver disease Academic Article
-
Recombinant Factor VIIa in Multiple Surgery Academic Article
-
Recombinant activated factor VII for the treatment of life-threatening haemorrhage Academic Article
-
Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors Academic Article
-
Recommendations for the development of new anticoagulant drugs for pediatric use: communication from the SSC of the ISTH Academic Article
-
Recurrent fetomaternal transfusion in two consecutive pregnancies Academic Article
-
Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis Academic Article
-
Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial Academic Article
-
Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: A randomized trial Academic Article
-
Reduced‐dose direct oral anticoagulants (DOACs) in the extended treatment of venous thromboembolism: A systematic review and meta‐analysis—Response to Commentary Academic Article
-
Reduced‐dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta‐analysis Academic Article
-
Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin Academic Article
-
Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins Academic Article
-
Refining Risk Prediction for Recurrent Venous Thromboembolism: Can We Do Better? Academic Article
-
Relation of Extracardiac Vascular Disease and Outcomes in Patients With Diabetes (1.1 Million) Hospitalized for Acute Myocardial Infarction Academic Article
-
Relationship Between Dose, Anticoagulant Effect and the Clinical Efficacy and Safety of Heparin Conference Paper
-
Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes Academic Article
-
Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive Heparin Academic Article
-
Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates Academic Article
-
Renal function and outcomes in acute coronary syndrome: impact of clopidogrel Academic Article
-
Repair of congenital diaphragmatic hernia after weaning from extracorporeal membrane oxygenation Conference Paper
-
Reply: regarding the effect of dabigatran plasma concentrations. Academic Article
-
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study Academic Article
-
Response to Letter Regarding Article, “Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin” Academic Article
-
Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”. Academic Article
-
Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding Patients Academic Article
-
Results of a Prospective Randomized Trial Evaluating Surgery Versus Thrombolysis for Ischemia of the Lower Extremity The STILE Trial Academic Article
-
Resuming warfarin after intracranial hemorrhage in patients with AF was linked to reduced mortality Academic Article
-
Retroperitoneal Hemorrhage After a Vaginal Mesh Prolapse Procedure Academic Article
-
Reversal agents for non-vitamin K antagonist oral anticoagulants Academic Article
-
Reversal of Direct Oral Anticoagulants: Current Status and Future Directions Academic Article
-
Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study Academic Article
-
Reversal of direct oral anticoagulants: a practical approach Academic Article
-
Reversal of novel oral anticoagulants in patients with major bleeding Academic Article
-
Reversal of target-specific oral anticoagulants Academic Article
-
Reversal of target-specific oral anticoagulants Academic Article
-
Reversal of vitamin K antagonist-associated coagulopathy: A survey of current practice Academic Article
-
Reversing Anticoagulant Therapy Academic Article
-
Review: In renal impairment, apixaban reduces, or does not increase, bleeding compared with other anticoagulants Academic Article
-
Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit) Academic Article
-
Risk and complications of venous thromboembolism in dialysis patients Academic Article
-
Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis Academic Article
-
Risk factors for bleeding in people living with hemophilia A and B treated with regular prophylaxis: A systematic review of the literature Academic Article
-
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation Academic Article
-
Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment Academic Article
-
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation Academic Article
-
Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants Academic Article
-
Risk of Haemorrhage Associated with Long Term Anticoagulant Therapy Academic Article
-
Risk of Stent Thrombosis and Major Bleeding with Bivalirudin Compared with Active Control: A Systematic Review and Meta-analysis of Randomized Trials Academic Article
-
Risk of bleeding with vitamin K antagonists compared with low-molecular-weight heparin after orthopedic surgery: a rebuttal Academic Article
-
Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism Academic Article
-
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage Academic Article
-
Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews Academic Article
-
Risks and Benefits of Anticoagulant Therapy Academic Article
-
Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials Academic Article
-
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial Academic Article
-
Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction Academic Article
-
Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease Academic Article
-
Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial Academic Article
-
Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions Academic Article
-
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial Academic Article
-
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source Academic Article
-
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness Academic Article
-
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer Academic Article
-
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: Pooled analysis of two studies Academic Article
-
Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation Academic Article
-
Rivaroxaban in Peripheral Artery Disease after Revascularization Academic Article
-
Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation Academic Article
-
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism Academic Article
-
Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers Academic Article
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial Academic Article
-
Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study Academic Article
-
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease Academic Article
-
Rivaroxaban with or without aspirin for prevention of cardiovascular disease Academic Article
-
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial Academic Article
-
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial Academic Article
-
Role of aspirin for prevention and treatment of perioperative cardiovascular events Academic Article
-
Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients Academic Article
-
Routine Ultrasonography Guidance for Femoral Vascular Access for Cardiac Procedures Academic Article
-
Rupture of an aneurysm of the splenic artery: an unusual cause of massive gastric hemmorrhage. Academic Article
-
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study Academic Article
-
Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE) Academic Article
-
Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: Experience in the standard clinical setting Academic Article
-
Safety of dalteparin for the prophylaxis of venous thromboembolism in elderly medical patients with renal insufficiency: a pilot study. Academic Article
-
Safety of lumbar punctures in patients with thrombocytopenia Academic Article
-
Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists Academic Article
-
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study Academic Article
-
Safety of thrombolysis in cerebral venous thrombosis Academic Article
-
Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic risk Academic Article
-
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19 Academic Article
-
Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran Academic Article
-
Secondary prevention of venous thromboembolism Academic Article
-
Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis Academic Article
-
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer Academic Article
-
Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE‐HIP1, SAVE‐HIP2 and SAVE‐KNEE Academic Article
-
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review Academic Article
-
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review: reply Academic Article
-
Sex-specific differences in adverse outcome events among patients with atrial fibrillation Academic Article
-
Sex‐Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD Academic Article
-
Shared Decision Making in the Management of Children With Newly Diagnosed Immune Thrombocytopenia Academic Article
-
Shared Decision-Making for Anticoagulation in Atrial Fibrillation: Do Physicians Really Listen? Academic Article
-
Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial Academic Article
-
Should vitamin K antagonist therapy be started simultaneously with parenteral anticoagulation Academic Article
-
Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study Academic Article
-
Socioeconomic Status and Differences in the Management and Outcomes of 6.6 Million US Patients With Acute Myocardial Infarction Academic Article
-
Socioeconomic status and risk of hemorrhage during warfarin therapy for atrial fibrillation: A population-based study Academic Article
-
Solving the mystery of excessive warfarin-induced bleeding: A personal historical perspective Academic Article
-
Specific antidotes for bleeding associated with direct oral anticoagulants Academic Article
-
Spotlight on animal models of acute traumatic coagulopathy: an update Academic Article
-
Standardized Bleeding Definitions for Cardiovascular Clinical Trials Academic Article
-
Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: A proposal from the Academic Bleeding Consensus (ABC) Multidisciplinary Working Group Academic Article
-
State of the Art-A Journey through the World of Antithrombotic Therapy Academic Article
-
Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves Academic Article
-
Strategies for the prevention and treatment of bleeding in patients treated with dabigatran: an update Academic Article
-
Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial Academic Article
-
Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease Academic Article
-
Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey Academic Article
-
Stroke prevention in atrial fibrillation: Closing the gap Academic Article
-
Stroke prevention in patients from Latin American countries with non‐valvular atrial fibrillation: Insights from the GARFIELD‐AF registry Academic Article
-
Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program Academic Article
-
Studies on the medical treatment of deep vein thrombosis. Academic Article
-
Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial Academic Article
-
Sub‐segmental pulmonary embolism in three academic teaching hospitals: a review of management and outcomes Academic Article
-
Suggestions for the management of factor VIII inhibitors Academic Article
-
Sulodexide versus Control and the Risk of Thrombotic and Hemorrhagic Events: Meta-Analysis of Randomized Trials Academic Article
-
Supplemental patient education for patients taking oral anticoagulants: systematic review and meta-analysis Academic Article
-
Susceptibility weighted imaging in detecting hemorrhage in acute cervical spinal cord injury Academic Article
-
Switching from standard to extended half‐life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokinetics Academic Article
-
Switching patients in the age of long-acting recombinant products? Academic Article
-
Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease Academic Article
-
Systematic Review of Observational Studies Assessing Bleeding Risk in Patients with Atrial Fibrillation Not Using Anticoagulants Academic Article
-
Systematic evaluation of the methodology of randomized controlled trials of anticoagulation in patients with cancer Academic Article
-
Systematic lower limb phlebography in acute spinal cord injury in 147 patients Academic Article
-
Systematic review and meta-analysis of outcomes in patients with suspected deep vein thrombosis Academic Article
-
Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism Academic Article
-
Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology Academic Article
-
THROMBOLYTIC THERAPY FOR VENOUS THROMBOEMBOLISM Academic Article
-
TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: A randomized controlled trial Academic Article
-
Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates Academic Article
-
Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes Academic Article
-
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation Academic Article
-
The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe? Academic Article
-
The Coagulation System in Humans Academic Article
-
The Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation Academic Article
-
The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism Academic Article
-
The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients Academic Article
-
The Efficacy and Safety of Heparin in Patients With Sepsis Academic Article
-
The Efficacy of Leukodepletion to Improve Platelet Transfusion Response: A Critical Appraisal of Clinical Studies Academic Article
-
The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis Academic Article
-
The Guideline-Policy Gap in Direct-Acting Oral Anticoagulants Usage in Atrial Fibrillation: Evidence, Practice, and Public Policy Considerations Academic Article
-
The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation Academic Article
-
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology Academic Article
-
The Impact of Uncross-Matched Blood Transfusion on the Need for Massive Transfusion and Mortality: Analysis of 5,166 Uncross-Matched Units Academic Article
-
The Incidence of Symptomatic Venous Thromboembolism During and After Prophylaxis With Enoxaparin<subtitle>A Multi-institutional Cohort Study of Patients Who Underwent Hip or Knee Arthroplasty</subtitle> Conference Paper
-
The Khorana score for the prediction of venous thromboembolism in patients with solid cancer: an individual patient data meta-analysis Conference Paper
-
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study Academic Article
-
The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE Academic Article
-
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale Academic Article
-
The Pharmacology and Management of the Vitamin K Antagonists Academic Article
-
The Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous Thromboembolism Academic Article
-
The Risk of Hemorrhage Among Patients With Warfarin-Associated Coagulopathy Academic Article
-
The Risk of Major Hemorrhage with CKD Academic Article
-
The aspirin controversy in primary prevention Academic Article
-
The association between cancer diagnosis, care, and outcomes in 1 million patients hospitalized for acute pulmonary embolism Academic Article
-
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events Academic Article
-
The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation Academic Article
-
The benefit-to-risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model Academic Article
-
The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions Academic Article
-
The clinical impact of bleeding during oral anticoagulant therapy Academic Article
-
The diagnosis and prevention of post operative venous thrombosis. Academic Article
-
The direct thrombin inhibitor hirudin Academic Article
-
The effect of aspirin on the size of the hemostatic plug Academic Article
-
The effects of rivaroxaban on the complications of surgery after total hip or knee replacement Academic Article
-
The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study Academic Article
-
The evolving treatment of peripheral arterial disease: preventing ischaemic events in the post-COMPASS era Academic Article
-
The fibrinogen but not the Factor VIII content of transfused plasma determines its effectiveness at reducing bleeding in coagulopathic mice Academic Article
-
The haemorrhagic and antithrombotic effects of dermatan sulphate. Academic Article
-
The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis Academic Article
-
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial Academic Article
-
The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians Academic Article
-
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study Academic Article
-
The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients Academic Article
-
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study Academic Article
-
The relationship between ex vivo anti-factor Xa levels and efficacy/safety of low molecular weight heparin. Academic Article
-
The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits Academic Article
-
The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation. Academic Article
-
The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia. Academic Article
-
The risk of iatrogenic bleeding in acute coronary syndromes and long-term mortality Academic Article
-
The risk of major bleeding in patients with suspected heparin‐induced thrombocytopenia Academic Article
-
The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial Academic Article
-
The safety of fondaparinux for the prevention and treatment of venous thromboembolism Academic Article
-
The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulants Academic Article
-
The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta‐analysis of a diagnostic test Academic Article
-
The thrombolytic and hemorrhagic effects of tissue type plasminogen activator: Influence of dosage regimens in rabrits Academic Article
-
The value of bleeding scores in the assessment of patients presenting with bleeding of unknown cause: Complex algorithms with little predictive value Academic Article
-
The value of monitoring heparin therapy in the prevention of recurrence in patients with venous thromboembolic disease. Academic Article
-
Theoretical and Practical Aspects of Thrombolytic Therapy Academic Article
-
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 Academic Article
-
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 Academic Article
-
Therapeutic strategies for thrombosis: new targets and approaches Academic Article
-
Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE]) Academic Article
-
Thromboembolic Complications in Pediatric Hematologic Malignancies Academic Article
-
Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy Academic Article
-
Thromboembolism in children with sarcoma Academic Article
-
Thromboembolism prevention in ischaemic stroke Academic Article
-
Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism Academic Article
-
Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review. Academic Article
-
Thrombolytic Therapy for Submassive Pulmonary Embolism? Academic Article
-
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial Academic Article
-
Thromboprophylaxis after knee arthroscopy does not decrease the risk of deep vein thrombosis: a network meta-analysis Academic Article
-
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials Academic Article
-
Thrombosis and anticoagulation in the setting of renal or liver disease Academic Article
-
Thrombotic and Hemorrhagic Complications in Children With the Lupus Anticoagulant Academic Article
-
Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study Academic Article
-
Time to rethink clinically important outcomes in platelet transfusion trials Academic Article
-
Tossing a coin or using common sense Academic Article
-
Tourniquet use for peripheral vascular injuries in the civilian setting Academic Article
-
Tranexamic Acid in Patients Undergoing Noncardiac Surgery Academic Article
-
Tranexamic acid in coronary artery surgery: One-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trial Academic Article
-
Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. Academic Article
-
Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine Academic Article
-
Transition from apixaban to warfarin—addressing excess stroke, systemic embolism, and major bleeding Academic Article
-
Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies Academic Article
-
Treatment and prevention of acute bleedings in von Willebrand disease - efficacy and safety of Wilate®, a new generation von Willebrand factor/factor VIII concentrate Academic Article
-
Treatment of Acute Coronary Syndromes Academic Article
-
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis Academic Article
-
Treatment of Venous Thrombosis in the Cancer Patient Academic Article
-
Treatment of Warfarin-Associated Coagulopathy Academic Article
-
Treatment of acute ischemic stroke: from fibrinolysis to neurointervention Academic Article
-
Treatment of bleeding complications in patients on anticoagulant therapy Academic Article
-
Treatment of coumarin‐associated coagulopathy: a systematic review and proposed treatment algorithms Academic Article
-
Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis Academic Article
-
Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study Academic Article
-
Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial Academic Article
-
Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer Academic Article
-
Treatment with novel oral anticoagulants Academic Article
-
Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI Academic Article
-
Twelve‐month outcomes and predictors of very stable INR control in prevalent warfarin users Academic Article
-
Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism Academic Article
-
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF Academic Article
-
Ulnar neuropathy resulting from diffuse intramuscular hemorrhage: A case report Academic Article
-
Unanswered questions in venous thromboembolism Academic Article
-
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis Academic Article
-
Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti‐factor Xa levels Academic Article
-
Unilateral suprarenal hemorrhage in a teenager: A case of TAFRO Academic Article
-
Update on diagnostic testing for platelet function disorders: What is practical and useful? Academic Article
-
Update on heparin: what do we need to know? Academic Article
-
Uremic bleeding: Pathophysiology and clinical risk factors Academic Article
-
Urgent Need to Measure Effects of Direct Oral Anticoagulants Academic Article
-
Urgent procedures or surgeries in patients receiving oral anticoagulants: a systematic literature review Academic Article
-
Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial Academic Article
-
Use of Warfarin in People with Low Glomerular Filtration Rate or on Dialysis Academic Article
-
Use of antithrombotic agents during pregnancy. Academic Article
-
Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients Academic Article
-
Use of plasminogen activators in venous thrombosis Academic Article
-
Use of warfarin (coumarin). Academic Article
-
Using low molecular weight heparin in special patient populations Academic Article
-
Utility of a Nurse-Led Pathway for Patients with Acute Venous Thromboembolism Discharged on Rivaroxaban: A Prospective Cohort Study Academic Article
-
Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses Academic Article
-
Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia Academic Article
-
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC Academic Article
-
Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives Academic Article
-
Variability in platelet dense granule adenosine triphosphate release findings amongst patients tested multiple times as part of an assessment for a bleeding disorder Academic Article
-
Variation in bleeding risk estimates among online calculators Academic Article
-
Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation Academic Article
-
Venous Thromboembolism in Older Adults: A Community-based Study Academic Article
-
Venous limb gangrene and fatal hemorrhage: Adverse consequences of hit “overdiagnosis” in a patient with antiphospholipid syndrome Academic Article
-
Venous thromboembolism and bleeding in a community setting Academic Article
-
Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin prophylaxis: prevalence, incidence and risk factors Academic Article
-
Venous thromboembolism in the elderly Academic Article
-
Vitamin K deficiency and D-dimer levels in the intensive care unit: a prospective cohort study Academic Article
-
Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis Academic Article
-
Vitamin K in anticoagulation therapy Academic Article
-
Vitamin K versus warfarin interruption alone in patients without bleeding and an international normalized ratio > 10 Academic Article
-
Warfarin After Bioprosthetic Aortic Valve Implantation Academic Article
-
Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios Academic Article
-
Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis Academic Article
-
Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial Academic Article
-
Warfarin and Aspirin after Heart-Valve Replacement Academic Article
-
Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm Academic Article
-
Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis Academic Article
-
Warfarin use in atrial fibrillation: A random sample survey of family physician beliefs and preferences. Academic Article
-
Weight‐adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery Academic Article
-
What we have learned about direct oral anticoagulant reversal Academic Article
-
What's the Incidence of Delayed Splenic Bleeding in Children After Blunt Trauma? An Institutional Experience and Review of the Literature Academic Article
-
When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH Academic Article
-
When guidelines collide Academic Article
-
When is it safe to stop for safety? Academic Article
-
Why Is Factor Xa Not a Better Target Than Factor IIa for Therapeutic Inhibition of Coagulation? Academic Article
-
Will prasugrel supersede clopidogrel for acute coronary syndromes? Academic Article
-
World bleeding disorders registry: The pilot study Academic Article
-
Ximelagatran or Warfarin for Stroke Prevention in Patients With Atrial Fibrillation? Academic Article
-
[Antithrombotic treatment of atrial fibrillation]. Academic Article
-
[Difficulties in obtaining financial support for studies of hemorrhage during treatment with anticoagulants]. Academic Article
-
[Elimination of antibodies against coagulation factor VIII: Factor VIIa is the most promising therapeutic alternative]. Academic Article
-
[One case of concurrent hemorrhage after pancreatic islet transplantation by percutaneous transhepatic portal approach]. Academic Article
-
[Prothromplex in stead of Beriplex P/N as acute antidote against warfarin]. Academic Article
-
o-Raffinose cross-linked hemoglobin improves the hemostatic defect associated with anemia and thrombocytopenia in rabbits Academic Article
-
von Willebrand Factor: Form for Function Academic Article
-
von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis Academic Article
-
Ácido tranexâmico no tratamento da hemorragia no trauma Academic Article